Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Eden Research plc (EDEN) Ordinary 1p

Sell:7.70p Buy:8.25p 0 Change: No change
Market closed Prices as at close on 22 January 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:7.70p
Buy:8.25p
Change: No change
Market closed Prices as at close on 22 January 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:7.70p
Buy:8.25p
Change: No change
Market closed Prices as at close on 22 January 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Eden Research plc is a technology development and commercialization company. The Company focuses on plant protection, animal and human health, and biocides. The Company's segments include Biocides, Human health and Agrochemicals. It offers a range of product categories, such as Foliar Diseases Control, including Botrytis, Botrytis Trail Data and Powdery Mildew; Soil Pest, including Nematodes and New Nematode Data; Protected Glass House Crops, including Spider Mites, Spider Mite Trail Data, Whitefly, Whitefly Trail Data and Powdery Mildew; Vascular Diseases Control, including Esca, Eutypa and Pierce's Diseases, and Post-Harvest Applications. Its encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses.

Contact details

Address:
Priory Crt
Business Park, 6 Priory Court
CIRENCESTER
GL7 5JB
United Kingdom
Telephone:
+44 (01285) 359555
Website:
www.edenresearch.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 14 January 2020 14/01/20
Interim results 18 September 2019 18/09/19
AGM 14 May 2019 14/05/19
Annual report 16 April 2019 16/04/19
Final results 02 April 2019 02/04/19

General stock information

EPIC:
EDEN
ISIN:
GB0001646941
Market cap:
£16.52 million
Shares in issue:
207.19 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Sean Smith
    Chief Executive Officer, Executive Director
  • Alex Abrey
    Chief Financial Officer, Executive Director
  • Robin Sims
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.